Statistics for Hyloris Pharmaceuticals SA (id:380 HYL)

Valuation metrics

Market cap

129.08M

Enterprise value

98.81M

Trailing P/E (ttm)

-8.53

Forward P/E

-7.44

PEG ratio

-0.28

Price/Sales (ttm)

18.60

Price/Book (mrq)

3.60

Enterprise Value/Revenue

14.24

Enterprise Value/EBITDA

-7.31

Overview

Shares outstanding

28.00M

Float

12.54M

Shares short

% Held by insiders

0.57%

% Held by institutions

0.00%

Average volume (10 days)

9.61K

Average volume (90 days)

Price summary

52-Week low

2.89

52-Week high

13.30

52-Week change

-162.50%

Beta

0.45

50-Day moving average

5.71

200-Day moving average

9.62

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

December 31th, 2023

Profitability

Profit margin

-190.79%

Operating margin

-84.72%

Operational effectiveness

Return on assets

-16.75%

Return on equity

-31.76%

Income statement

Revenue (ttm)

0.24

Revenue per share (ttm)

0.24

Quarterly revenue growth (yoy)

Gross profit (ttm)

1.99M

EBITDA

-13,525,000.00

Net income to common (ttm)

-13,243,000.00

Diluted EPS (ttm)

-0.55

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

27.96M

Total cash per share (mrq)

0.96

Total debt (mrq)

1.89M

Total Debt/Equity (mrq)

5.44

Current ratio (mrq)

371.10%

Book value per share (mrq)

1.19

Cash flow

Cash flow statement

-12,015,000.00

Levered free cash flow (LFCF)

-6,919,875.00